| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 08/16/1995 | CN1106812A Tricyclic diazepine vasopressin antagonists |
| 08/16/1995 | CN1106805A Sulfonamide endothelin antagonists |
| 08/16/1995 | CN1106804A 1-Benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives |
| 08/16/1995 | CN1106802A Tricyclic benzazepine vasopressin antagonists |
| 08/15/1995 | US5441986 Estrogen agonists as remedies for prostate and cardiovascular diseases |
| 08/15/1995 | US5441985 Administring tomoxetin for incontinence; negligible anti-cholinergic effect |
| 08/15/1995 | US5441966 Methods of inhibiting Turner's syndrome |
| 08/10/1995 | WO1995020972A1 Treatment of ovarian estrogen dependent conditions |
| 08/09/1995 | EP0665834A1 Quinolone and acridinone derivatives for the treatment of urinary incontinence |
| 08/09/1995 | EP0665833A1 Dopamine receptor subtype ligands |
| 08/09/1995 | EP0601123B1 Low speed model following velocity command system for rotary wing aircraft |
| 08/09/1995 | CN1106381A Orthosubstituted benzoylguanidine, preparation of same, pharmaceutical containing same and application of same |
| 08/08/1995 | US5440036 1,4-benzoxazine derivatives |
| 08/08/1995 | US5439931 Administering a stimulants to increase sexual drive |
| 08/08/1995 | US5439919 Treatment of urinary incontinence |
| 08/08/1995 | US5439913 Contraception method using competitive progesterone antagonists and novel compounds useful therein |
| 08/08/1995 | US5439895 4-aminoquinazoline derivatives |
| 08/08/1995 | CA1336579C Delivery systems for the controlled administration of lhrh analogs |
| 08/03/1995 | WO1995020600A1 Immunogens against gonadotropin releasing hormone |
| 08/03/1995 | WO1995020579A1 Cyanoguanidines as k-channel blockers |
| 08/03/1995 | WO1995020578A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS |
| 08/03/1995 | CA2179036A1 Cyanoguanidines as k-channel blockers |
| 08/02/1995 | EP0665227A1 Polyhydronorharman synthase inhibitors |
| 08/02/1995 | EP0664811A1 Gestagenically active 19,11-bridged 4-estrenes. |
| 08/02/1995 | EP0664801A1 Amide derivatives |
| 08/02/1995 | EP0664700A1 Treatment of cachexia and inhibition of il-6 activity |
| 08/02/1995 | CN1106007A Novel sulfonylamino pyrimidines |
| 08/01/1995 | US5438134 Process for the production of unsaturated 17 α-cyanomethyl-17 β-h |
| 08/01/1995 | US5438063 Hypotensive agents, cardiac insufficiency, increased intraocular pressure, and CNS disorders |
| 08/01/1995 | CA2141231A1 6-azaindole thromboxane synthase inhibitors |
| 08/01/1995 | CA2140953A1 Polyhydronorharman synthase inhibitors |
| 08/01/1995 | CA1336492C Treatment of genital warts with a combination of podophyllin and recombinant dna human alpha interferon |
| 07/27/1995 | WO1995019978A1 Tetracyclic derivatives, process of preparation and use |
| 07/27/1995 | WO1995019959A1 Amino acid derivatives and their use as phospholipase a2 inhibitors |
| 07/27/1995 | WO1995019774A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 07/27/1995 | CA2177372A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 07/26/1995 | EP0664125A1 Inhibition of myeloperoxidase activity |
| 07/26/1995 | EP0664124A1 Treatment of atrophy of the skin and vagina |
| 07/26/1995 | EP0664122A1 Inhibition of imperfect tissue repair |
| 07/26/1995 | EP0663827A1 Tocolytic oxytocin receptor antagonists |
| 07/26/1995 | EP0663822A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine |
| 07/26/1995 | CN1105583A Prescription of chun wine and preparation technology thereof |
| 07/25/1995 | US5436233 Nervous system disorders |
| 07/25/1995 | US5436137 Promoting fertilization |
| 07/25/1995 | CA2140813A1 Use of flavolignans as adjuvants in tumor therapy |
| 07/25/1995 | CA2140722A1 Beta-carboline thromboxane synthase inhibitors |
| 07/25/1995 | CA2022323C Excretion of potassium ion by prostanoic acid derivatives |
| 07/25/1995 | CA1336403C Human relaxin formulation |
| 07/25/1995 | CA1336400C Method for treating renal diseases |
| 07/20/1995 | WO1995019434A1 Tissue-specific enhancer active in prostate |
| 07/20/1995 | WO1995019431A1 Zinc finger protein derivatives and methods therefor |
| 07/20/1995 | WO1995019372A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 07/19/1995 | EP0663398A1 Dihydrate of N-(4-amino-6,7-dimethoxyquinazol-2-yl)-N-methyl-N'-(tetrahydrofuroyl-2)-propylene diamine hydrochloride (= alfuzosin hydrochloride dihydrate) and a process for the preparation |
| 07/19/1995 | EP0663014A1 Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 07/19/1995 | EP0662950A1 Benzenealkanoic acids for cardiovascular diseases |
| 07/19/1995 | EP0662839A1 Vaccines and antigenic conjugates |
| 07/19/1995 | EP0662834A1 Novel epoxide-containing compounds |
| 07/18/1995 | US5434176 Phenylimidazolidines |
| 07/18/1995 | US5434173 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity |
| 07/18/1995 | US5434162 Quinolinyl/isoquinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 07/18/1995 | US5434146 Antitumor, breast cancer |
| 07/13/1995 | WO1995018803A1 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| 07/13/1995 | CA2180360A1 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| 07/12/1995 | EP0662325A2 Inhibition of ovarian dysgenesis, delayed puberty, or sexual infantilism |
| 07/12/1995 | EP0661994A1 Method of prophylaxis of acute renal failure |
| 07/12/1995 | EP0661971A1 Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine |
| 07/12/1995 | EP0661970A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine |
| 07/12/1995 | EP0377665B1 Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine |
| 07/12/1995 | CN1104888A Pharmaceutical composition for preventing or treating arteriosclerosis |
| 07/11/1995 | US5432168 Method of treatment of hormone-unresponsive metastatic prostate cancer |
| 07/06/1995 | WO1995018226A1 Tuberous sclerosis 2 gene and uses thereof |
| 07/06/1995 | WO1995018225A1 Polycystic kidney disease 1 gene and uses thereof |
| 07/06/1995 | WO1995018128A1 Pyrazolopyridine adenosine antagonists |
| 07/06/1995 | WO1995018105A1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists |
| 07/06/1995 | WO1995017906A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 07/06/1995 | WO1995017904A2 Botulinum toxins for treating various disorders and associated pain |
| 07/06/1995 | WO1995017895A1 Means and method for hormonal contraception and/or the treatment of acne |
| 07/06/1995 | WO1995017887A1 Method of treatment of hormone-unresponsive metastatic prostate cancer |
| 07/06/1995 | CA2682117A1 The use of the neurotoxic component of a botulinum toxin for the treatment of a facial disease, disorder or condition |
| 07/06/1995 | CA2180253A1 Pyrazolopyridine adenosine antagonists |
| 07/06/1995 | CA2179422A1 Means and method for hormonal contraception and/or the treatment of acne |
| 07/05/1995 | EP0660716A1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 07/05/1995 | EP0660711A1 Novel use of inhibitors of phosphodiestersase iv |
| 07/05/1995 | CN1104637A Derivative of 2-aminopyrazine-5-carboxamide, preparation and pharmaceutical use of same |
| 07/04/1995 | US5430048 Spirocyclic benzopyran imidazolines |
| 07/04/1995 | US5429938 Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules |
| 07/04/1995 | CA1336223C Method of chain combination |
| 07/04/1995 | CA1336168C Method of preventing or treating toxemia in pregnancy using a thromboxane a_ receptor antagonist |
| 06/29/1995 | WO1995017411A1 Novel therapeutic carbohydrate blends useful for aiding premenstrual syndrome |
| 06/29/1995 | WO1995017410A1 Heterocyclic compounds |
| 06/29/1995 | WO1995017405A1 Indoline derivatives, method of preparation and their use as pharmaceuticals |
| 06/29/1995 | WO1995017194A1 Composition for a contraceptive comprising an estrogen and a gestagen |
| 06/29/1995 | WO1995014085A3 A method for detection of alterations in the dna mismatch repair pathway |
| 06/29/1995 | CA2179402A1 Indoline derivatives, method of preparation and their use as pharmaceuticals |
| 06/29/1995 | CA2177851A1 Heterocyclic compounds |
| 06/28/1995 | EP0659747A1 Branched aminothiazole derivatives process for their preparation and pharmaceutical compositions containing them |
| 06/28/1995 | EP0659424A1 2-Phenyl-3-azoylbenzothiophenes for treating male infertility |
| 06/28/1995 | EP0659422A1 2-Phenyl-3-azoylbenzothiophenes for treating Turner's syndrome |
| 06/28/1995 | EP0659421A1 2-Phenyl-3-azoylbenzothiophenes for treating menstrual symptoms |
| 06/28/1995 | EP0659420A1 2-Phenyl-3-azoylbenzothiophenes for treating sexual precocity |